Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 September 2008, Vol. 112, No. 5, pp. 1784-1793.
Prepublished online as a Blood First Edition Paper on June 25, 2008; DOI 10.1182/blood-2008-02-142745.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
blood-2008-02-142745v1
112/5/1784    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Avery, D. T
Right arrow Articles by Tangye, S. G
PubMed
Right arrow PubMed Citation
Right arrow Articles by Avery, D. T
Right arrow Articles by Tangye, S. G
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted February 28, 2008
Accepted June 4, 2008

STAT3 is required for IL-21-induced secretion of IgE from human naive B cells

Danielle T Avery, Cindy S Ma, Vanessa L Bryant, Brigitte Santner-Nanan, Ralph Nanan, Melanie Wong, David A Fulcher, Matthew C Cook, and Stuart G Tangye*

Immunology & Inflammation, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia
Discipline of Paediatrics, Nepean Clinical School, University of Sydney, Penrith, NSW, Australia
Department of Immunology and Allergy, Children's Hospital, Westmead, Westmead, NSW, Australia
Immunology Unit, Institute of Clinical Pathology and Medical Research,, Westmead Hospital, Westmead, NSW, Australia
Department of Immunology, The Canberra Hospital, Woden, ACT, Australia

* Corresponding author; email: s.tangye{at}garvan.org.au.

The production of IgE is tightly regulated. This is evidenced by the fact that it comprises <0.0001% of serum Ig, and aberrant production causes atopic conditions including allergy, rhinitis and anaphylaxis. IL-4 is a well-characterised inducer of IgE by human and murine B cells, while IFN-{gamma} can antagonise this effect. IL-21 has also been recognised for its ability to suppress IL-4-induced IgE production by murine B cells. Here, we identified IL-21 as an inducer of IgE production by CD40L-stimulated human naive B cells. Furthermore, there was a striking synergistic effect between IL-4 and IL-21 on inducing IgE secretion by all subsets of CD40L-stimulated human B cells, such that the levels detected under these conditions exceeded those induced by IL-4 or IL-21 alone by >10 fold. IL-21 induced activation of STAT3 and analysis of B cells from patients with loss-of-function STAT3 mutations revealed that the ability of IL-21 to induce IgE secretion, and augment that driven by IL-4, was STAT3-dependent. These findings highlight a fundamental difference between the regulation of IgE production by human and murine B cells and have implications for the dysregulated production of IgE in conditions characterised by extremely high levels of serum IgE.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020